The Indira Gandhi International Airport will soon have a climate-controlled pharma zone to ensure that the quality of imported and exported drugs is maintained. The first of its kind,it will involve infrastructure costs of around Rs 7 crore,besides the cost of land.
A separate dedicated temperature and atmosphere controlled area,a pharma zone is meant to maintain the safety,efficacy,and quality of drugs and pharma products in line with the product requirements and Good Manufacturing Practices (GMP) compliance within the cargo premises of ports.
At present,the Indian Central Drugs Control Organisation (CDSCO) is seeking feedback from stakeholders on plans to create pharma zones within the cargo area of all major airports and seaports,starting with the Capital.
The area would be used for proper storage and examination of pharmaceutical products keeping in mind manufacturing and distribution practices. They would help preserve the quality of pharmaceuticals being transported and ensure there is no cross-contamination of medicines with other products, said Dr Surender Singh,Drug Controller General of India (DGCI).
Stakeholders have until June 15 to submit comments on the draft plan.
The draft plan for the pharma zone at IGI Airport contains a macro layout of the proposed facility,which would be spread over an area of approximately 3,700 square metres.
It would include,among other things,a cold room facility with varied temperature zones (-20 to 8 degrees C) and a comfort zone (with temperatures below 25 degrees C) for examination of pharmaceuticals. It would have a basic testing facility to check samples and also house the offices of the Additional Drug Controller (India) and other regulatory authorities.
The layout is expected to be finalised by the end of the month and it is up to the private developers to decide on the operationalising of the zone.